Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Jane Winter

She will lead the CRO's global consulting practice

INC Research CRO contract research Jane WinterINC Research has appointed industry veteran Jane Winter to lead its global consulting practice.

She has worked in the industry for 30 years of industry, most recently as interim global head of outsourcing at a Japanese biopharmaceutical company.

Earlier in her career Winter spent 11 years with Quintiles and three year with Wyeth (now part of Pfizer).

She currently serves on the board of directors for the Pan–Asian Clinical Research Association (PACRA), a non-profit organisation in Singapore dedicated to the professional development of clinical research personnel based in Asia Pacific.

As INC's senior vice president of global consulting Winter will be based in the UK and lead the CRO's unit that provides consulting in areas such as drug development and commercialisation and quality assurance.

Alistair Macdonald, INC's chief operating officer, said: “[Jane's] leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimisation and compliance.

“These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers' most pressing business needs in drug development today.”

26th February 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics